A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants

Proteome Science

Volumn 8, Issue , 2010, Pages

  De Petris, Luigi ^a   Pernemalm, Maria ^a   Elmberger, Göran ^b   Bergman, Per ^b   Orre, Lotta ^b   Lewensohn, Rolf ^a   Lehtiö, Janne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; HEMOGLOBIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UBIQUITIN;

ARTICLE; CANCER TISSUE; CELL LYSATE; CELL SUSPENSION; CLINICAL PROTOCOL; CONTAMINATION; CONTROLLED STUDY; CYTOPATHOLOGY; ENRICHMENT CULTURE; FEASIBILITY STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MASS SPECTROMETRY; MICROSCOPY; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TISSUE PREPARATION;

EID: 77949342205     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-8-9     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
2. Au JS, Cho WC, Yip TT, Law SC. Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Invest 2008, 26:128-135. 10.1080/07357900701788031, 18259942.
3. Deng B, Ye N, Luo G, Chen X, Wang Y. Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues. Cancer Biomark 2005, 1:279-286.
4. He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, et al. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 2007, 98:1234-1240. 10.1111/j.1349-7006.2007.00509.x, 17506794.
5. Maeda J, Hirano T, Ogiwara A, Akimoto S, Kawakami T, Fukui Y, Oka T, Gong Y, Guo R, Inada H, et al. Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Br J Cancer 2008, 98:596-603. 10.1038/sj.bjc.6604197, 2243141, 18212748.
6. Okano T, Kondo T, Fujii K, Nishimura T, Takano T, Ohe Y, Tsuta K, Matsuno Y, Gemma A, Kato H, et al. Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin Cancer Res 2007, 13:799-805. 10.1158/1078-0432.CCR-06-1654, 17289870.
7. Lengqvist J, Uhlen K, Lehtio J. iTRAQ compatibility of peptide immobilized pH gradient isoelectric focusing. Proteomics 2007, 7:1746-1752. 10.1002/pmic.200600782, 17476709.
8. Eriksson H, Lengqvist J, Hedlund J, Uhlen K, Orre LM, Bjellqvist B, Persson B, Lehtio J, Jakobsson PJ. Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms. Proteomics 2008, 8:3008-3018. 10.1002/pmic.200800174, 18654985.
9. Pernemalm M, De Petris L, Eriksson H, Branden E, Koyi H, Kanter L, Lewensohn R, Lehtio J. Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion. Proteomics 2009, 9:3414-3424. 10.1002/pmic.200800814, 19609957.
10. Young GD, Winokur TS, Cerfolio RJ, Van Tine BA, Chow LT, Okoh V, Garver RI. Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes. Lung Cancer 2002, 36:133-141. 10.1016/S0169-5002(01)00486-X, 11955647.
11. Fukaya Y, Shimada H, Wang LC, Zandi E, DeClerck YA. Identification of galectin-3-binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma. J Biol Chem 2008, 283:18573-18581. 10.1074/jbc.M803115200, 18450743.
12. Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets 2008, 8:243-252. 10.2174/156800908784533445, 18537548.
13. Bloom GC, Eschrich S, Zhou JX, Coppola D, Yeatman TJ. Elucidation of a protein signature discriminating six common types of adenocarcinoma. Int J Cancer 2007, 120:769-775. 10.1002/ijc.22041, 17131332.
14. Gharib TG, Chen G, Wang H, Huang CC, Prescott MS, Shedden K, Misek DE, Thomas DG, Giordano TJ, Taylor JM, et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 2002, 4:440-448. 10.1038/sj.neo.7900257, 1661678, 12192603.
15. Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C, Li F, Chen YH, Yi H, Yao HX, Chen ZC. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 2009, 217:54-64. 10.1002/path.2429, 18798225.
16. Yao H, Zhang Z, Xiao Z, Chen Y, Li C, Zhang P, Li M, Liu Y, Guan Y, Yu Y, Chen Z. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 2009, 65:41-48. 10.1016/j.lungcan.2008.10.024, 19058872.
17. VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, et al. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 2008, 7:1902-1924. 10.1074/mcp.M800204-MCP200, 2559935, 18687633.
18. Guo T, Wang W, Rudnick PA, Song T, Li J, Zhuang Z, Weil RJ, DeVoe DL, Lee CS, Balgley BM. Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens. J Histochem Cytochem 2007, 55:763-772. 10.1369/jhc.7A7177.2007, 17409379.
19. Sprung RW, Brock JW, Tanksley JP, Li M, Washington MK, Slebos RJ, Liebler DC. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 2009, 8:1988-1998. 10.1074/mcp.M800518-MCP200, 2722776, 19467989.
20. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003, 362:433-439. 10.1016/S0140-6736(03)14068-8, 12927430.
21. Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst 2007, 99:858-867. 10.1093/jnci/djk197, 17551146.
22. Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, Chaurand P, Yanagisawa K, Slovis BS, Miller RF, et al. Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med 2005, 172:1556-1562. 10.1164/rccm.200502-274OC, 2718455, 16179643.
23. Forsberg L, Larsson C, Sofiadis A, Lewensohn R, Hoog A, Lehtio J. Pre-fractionation of archival frozen tumours for proteomics applications. J Biotechnol 2006, 126:582-586. 10.1016/j.jbiotec.2006.05.020, 16956687.
24. Kellner U, Steinert R, Seibert V, Heim S, Kellner A, Schulz HU, Roessner A, Kruger S, Reymond M. Epithelial cell preparation for proteomic and transcriptomic analysis in human pancreatic tissue. Pathol Res Pract 2004, 200:155-163. 10.1016/j.prp.2004.03.001, 15237924.
25. Lee EJ, In KH, Kim JH, Lee SY, Shin C, Shim JJ, Kang KH, Yoo SH, Kim CH, Kim HK, et al. Proteomic analysis in lung tissue of smokers and COPD patients. Chest 2009, 135:344-352. 10.1378/chest.08-1583, 18753468.
26. Calvo FQ, Fillet M, de Seny D, Meuwis MA, Maree R, Crahay C, Paulissen G, Rocks N, Gueders M, Wehenkel L, et al. Biomarker discovery in asthma-related inflammation and remodeling. Proteomics 2009, 9:2163-2170. 10.1002/pmic.200800643, 19322781.